Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Neuropsychobiology|July 3, 2009
Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese populationTaro Kishi, Tsuyoshi Kitajima, Masashi Ikeda, et al.
Biological Psychiatry|July 5, 2005
Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patientsMasashi Ikeda, Nakao Iwata, Tatsuyo Suzuki, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 19, 2026
Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysisMasakazu Okazaki, Kenji Sakuma, Hikaru Jo, et al.
Psychiatry Research|June 26, 2026
Light exposure at night and subjective and objective sleep parameters in patients with schizophrenia: A cross-sectional analysis of the LENS studyRyota Miyake, Yuichi Esaki, Rina Taniguchi, et al.
Psychopharmacology|February 24, 2010
Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophreniaTaro Kishi, Masatsugu Moriwaki, Tsuyoshi Kitajima, et al.
Neuroscience Letters|January 6, 2005
No association was found between a functional SNP in ZDHHC8 and schizophrenia in a Japanese case-control populationShinichi Saito, Masashi Ikeda, Nakao Iwata, et al.
Neuroscience Research|December 23, 2009
Investigation of clinical factors influencing cognitive function in Japanese schizophreniaTaro Kishi, Masatsugu Moriwaki, Kunihiro Kawashima, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 3, 2008
Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Human Psychopharmacology|August 26, 2010
Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese populationTaro Kishi, Yasuhisa Fukuo, Reiji Yoshimura, et al.
Pharmacogenomics|October 16, 2008
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophreniaMasashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, et al.
Pageof 12